Search All UT System Experts

Treatment of triple-negative breast cancer with TORC1/2 inhibitors sustains a drug-resistant and notch-dependent cancer stem cell population

Neil E. Bhola, Valerie M. Jansen, James P. Koch, Hua Li, Luigi Formisano, Janice A. Williams, Jennifer R. Grandis, Carlos L. Arteaga

Research output: Contribution to journal › Article › peer-review

81 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of triple-negative breast cancer with TORC1/2 inhibitors sustains a drug-resistant and notch-dependent cancer stem cell population'. Together they form a unique fingerprint.

Medicine & Life Sciences